Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

NHTC

Natural Health Trends Corp.

May 10 • 04:00PM ET

7.35

Dollar change +0.20
Percentage change 2.80	%

Consumer Cyclical • Internet Retail • Hong Kong • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF IWC DFAC DFUS DFAT

Index	-	P/E	168.97	EPS (ttm)	0.04	Insider Own	34.93%	Shs Outstand	11.52M	Perf Week	6.52%
Market Cap	84.67M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.49M	Perf Month	10.36%
Income	0.50M	PEG	-	EPS next Q	-	Inst Own	10.24%	Short Float	0.15%	Perf Quarter	17.79%
Sales	43.01M	P/S	1.97	EPS this Y	-	Inst Trans	-5.66%	Short Ratio	0.51	Perf Half Y	27.16%
Book/sh	3.42	P/B	2.15	EPS next Y	-	ROA	0.68%	Short Interest	0.01M	Perf Year	27.83%
Cash/sh	4.72	P/C	1.56	EPS next 5Y	-	ROE	1.14%	52W Range	4.90 - 7.24	Perf YTD	25.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-55.18%	ROI	1.20%	52W High	1.54%	Beta	0.81
Dividend TTM	0.80 (10.88%)	Quick Ratio	2.77	Sales past 5Y	-22.33%	Gross Margin	73.94%	52W Low	50.00%	ATR (14)	0.20
Dividend Ex-Date	May 13, 2024	Current Ratio	3.01	EPS Y/Y TTM	-26.35%	Oper. Margin	-3.82%	RSI (14)	72.23	Volatility	2.52% 2.64%
Employees	139	Debt/Eq	0.09	Sales Y/Y TTM	-13.01%	Profit Margin	1.16%	Recom	-	Target Price	-
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	-27.11%	Payout	1612.90%	Rel Volume	6.37	Prev Close	7.15
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-7.67%	Earnings	May 01 BMO	Avg Volume	21.93K	Price	7.35
SMA20	9.01%	SMA50	11.08%	SMA200	24.79%	Trades		Volume	139,606	Change	2.80%

May-02-24 12:31PM	Natural Health Trends Corp. (NASDAQ:NHTC) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:04AM	Q1 2024 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
May-01-24 01:53PM	NHTC Stock Earnings: Natural Health Trends Reported Results for Q1 2024 (InvestorPlace)
09:05AM	Natural Health Trends: Q1 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports First Quarter 2024 Financial Results (GlobeNewswire)
09:00AM	Loading…
Apr-24-24 09:00AM	Natural Health Trends to Report First Quarter 2024 Financial Results on May 1st (GlobeNewswire)
Apr-16-24 02:52AM	12 Highest Yielding Dividend Stocks You Can Buy Right Now (Insider Monkey)
Mar-17-24 08:38AM	15 Highest Quality Probiotics For Gut Health (Insider Monkey)
Feb-08-24 09:03AM	Natural Health Trends Corp. (NASDAQ:NHTC) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:03AM	Q4 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 09:17AM	Natural Health Trends: Q4 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-31-24 09:00AM	Natural Health Trends to Report Fourth Quarter 2023 Financial Results on February 7th (GlobeNewswire)
Nov-16-23 12:18PM	12 Best Debt Free Stocks To Buy (Insider Monkey)
Nov-02-23 10:16AM	Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:42AM	Loading…
12:42AM	Q3 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 10:32AM	Natural Health Trends Corp (NHTC) Reports Q3 2023 Earnings: Cash Flows Improve by $1.4 Million (GuruFocus.com)
09:12AM	Natural Health Trends: Q3 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 09:00AM	Natural Health Trends to Report Third Quarter 2023 Financial Results on November 1st (GlobeNewswire)
Aug-03-23 01:35AM	Q2 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-02-23 09:05AM	Natural Health Trends: Q2 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 09:00AM	Natural Health Trends to Report Second Quarter 2023 Financial Results on August 2nd (GlobeNewswire)
Jul-12-23 06:32AM	Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 62% over the last five years (Simply Wall St.)
May-04-23 12:43AM	Q1 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
May-03-23 09:08AM	Natural Health Trends: Q1 Earnings Snapshot (AP Finance) -10.34%
09:00AM	Natural Health Trends Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 09:00AM	Natural Health Trends to Report First Quarter 2023 Financial Results on May 3rd (GlobeNewswire)
Apr-21-23 10:21AM	Calculating The Intrinsic Value Of Natural Health Trends Corp. (NASDAQ:NHTC) (Simply Wall St.)
05:35AM	Loading…
Feb-10-23 05:35AM	Natural Health Trends Full Year 2022 Earnings: EPS: US$0.028 (vs US$0.098 in FY 2021) (Simply Wall St.)
Feb-08-23 09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +10.08%
Feb-01-23 09:00AM	Natural Health Trends to Report Fourth Quarter 2022 Financial Results on February 8th (GlobeNewswire)
Jan-12-23 08:44AM	Investors Could Be Concerned With Natural Health Trends' (NASDAQ:NHTC) Returns On Capital (Simply Wall St.)
Nov-12-22 07:24AM	A Look At The Fair Value Of Natural Health Trends Corp. (NASDAQ:NHTC) (Simply Wall St.)
Nov-02-22 09:00AM	Natural Health Trends Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-26-22 09:00AM	Natural Health Trends to Report Third Quarter 2022 Financial Results on November 2nd (GlobeNewswire)
Aug-22-22 08:09AM	Weak Financial Prospects Seem To Be Dragging Down Natural Health Trends Corp. (NASDAQ:NHTC) Stock (Simply Wall St.)
Aug-05-22 09:32AM	The Returns On Capital At Natural Health Trends (NASDAQ:NHTC) Don't Inspire Confidence (Simply Wall St.)
Aug-03-22 09:00AM	Natural Health Trends Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-27-22 09:00AM	Natural Health Trends to Report Second Quarter 2022 Financial Results on August 3rd (GlobeNewswire)
Jun-26-22 09:06AM	Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 67% over the last five years (Simply Wall St.)
Jun-03-22 06:22AM	Estimating The Intrinsic Value Of Natural Health Trends Corp. (NASDAQ:NHTC) (Simply Wall St.)
May-04-22 09:00AM	Natural Health Trends Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-27-22 09:00AM	Natural Health Trends to Report First Quarter 2022 Financial Results on May 4th (GlobeNewswire)
Mar-04-22 09:50AM	Can Mixed Financials Have A Negative Impact on Natural Health Trends Corp.'s 's (NASDAQ:NHTC) Current Price Momentum? (Simply Wall St.)
Feb-09-22 09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Feb-02-22 09:00AM	Natural Health Trends to Report Fourth Quarter and Full Year 2021 Financial Results on February 9th (GlobeNewswire)
Jan-03-22 09:14AM	Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 55% over the last five years (Simply Wall St.)
Nov-03-21 09:00AM	Natural Health Trends Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-27-21 09:00AM	Natural Health Trends to Report Third Quarter 2021 Financial Results on November 3rd (GlobeNewswire)
Oct-01-21 09:00AM	Natural Health Trends Announces Closing of Investigation by the SEC (GlobeNewswire)
Aug-16-21 12:20PM	Natural Health Trends Corp.'s (NASDAQ:NHTC) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? (Simply Wall St.) -10.90%
Aug-04-21 09:00AM	Natural Health Trends Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Jul-28-21 09:00AM	Natural Health Trends to Report Second Quarter 2021 Financial Results on August 4th (GlobeNewswire)
May-17-21 10:24AM	Would Shareholders Who Purchased Natural Health Trends' (NASDAQ:NHTC) Stock Five Years Be Happy With The Share price Today? (Simply Wall St.)
May-05-21 09:30AM	Natural Health Trends Corp. to Host Earnings Call (ACCESSWIRE)
09:00AM	Natural Health Trends Reports First Quarter 2021 Financial Results (GlobeNewswire)
Apr-28-21 09:00AM	Natural Health Trends to Report First Quarter 2021 Financial Results on May 5th (GlobeNewswire)
Mar-17-21 07:00AM	ASECNA Continues Enhancement of the Single African Sky Using Aireon's Space-Based ADS-B as an Essential Technology (PR Newswire)
Mar-09-21 06:59AM	BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting (PR Newswire)
Mar-07-21 11:48PM	Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching (Simply Wall St.)
Mar-04-21 06:59AM	BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings (PR Newswire) -6.05%
Feb-22-21 06:59AM	BD Announces Collaboration for At-Home Rapid Test for COVID-19 (PR Newswire) -12.66%
Feb-19-21 10:31AM	Understanding Natural Health Trends's Ex-Dividend Date (Benzinga)
Feb-15-21 02:15AM	Natural Health Trends Corp. (NASDAQ:NHTC) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? (Simply Wall St.)
Feb-14-21 04:08AM	Becton Dickinson Gets EUA For New Diagnostic Test (SmarterAnalyst)
Feb-13-21 10:00AM	30 Dividend Champions of 2021 (Part I) (Insider Monkey)
Feb-12-21 05:25PM	BD to Present at Upcoming Investor Conferences (PR Newswire) +6.72%
06:59AM	BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test (PR Newswire)
Feb-10-21 09:30AM	Natural Health Trends Corp. to Host Earnings Call (ACCESSWIRE)
09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2020 Financial Results (GlobeNewswire)
06:49AM	Becton Dickinson plans dual dollar/euro bond offerings to repay debt (MarketWatch)
Feb-08-21 10:11AM	Becton Dickinson Euro Finance S.a.r.l. -- Moody's assigns Baa3 rating to Becton Dickinson's senior unsecured notes (Moody's) +9.09%
Feb-06-21 01:21AM	Becton, Dickinson and Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next (Simply Wall St.)
Feb-05-21 11:28AM	7 Dividend Stocks Yielding Over 5% (InvestorPlace) +7.67%
Feb-04-21 06:00AM	BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance (PR Newswire)
Feb-03-21 09:00AM	Natural Health Trends to Report Fourth Quarter and Full Year 2020 Financial Results on February 10th (GlobeNewswire)
Feb-02-21 03:00AM	First-of-its-Kind Randomized Clinical Trial Published in "The Lancet Infectious Diseases" Outlines Potential New Standard-Setting Best Practices for Peripheral IV Catheters (PR Newswire)
Jan-26-21 08:15AM	Update in Lawsuit for Investors in shares of Becton, Dickinson and Company (NYSE: BDX) announced by Shareholders Foundation (GlobeNewswire)
06:59AM	BD Names CEO Tom Polen as Chairman of the Board (PR Newswire)
Jan-25-21 04:15PM	BD Board Declares Dividend (PR Newswire)
06:59AM	New Clinical Data Shows BD Antigen Test May Be More Selective In Detecting Infectious COVID-19 Patients Than Molecular Tests (PR Newswire)
Jan-19-21 03:11PM	Becton Dickinson Euro Finance S.a.r.l. -- Moody's upgrades Becton, Dickinson and Company to investment grade (senior unsecured rating to Baa3), outlook remains positive (Moody's)
Jan-18-21 11:59PM	Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX) (Simply Wall St.)
Jan-12-21 06:40AM	Becton Dickinson stock rallies after upbeat revenue outlook (MarketWatch)
06:00AM	BD Provides Updates To Its Fiscal 2021 Financial Outlook And Intends To Comment On Its Preliminary First Fiscal Quarter Revenue Performance During Today's Webcast At The 39th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-21 07:00AM	Why The Covid Pandemic Will Be A Boon For These Health Care Stocks (Investor's Business Daily)
Jan-05-21 06:57AM	15 Largest Medical Device Companies in the World (Insider Monkey)
Dec-22-20 07:14PM	BD to Present at the 39th Annual J.P. Morgan Healthcare Conference (PR Newswire)
01:34PM	Top 10 ESG Stocks Al Gores $25 Billion Hedge Fund Is Buying (Insider Monkey)
Dec-16-20 11:14AM	Coronavirus update: CDC funds COVID-19 vaccine distribution and monitoring; BD sees surge in syringe business (Yahoo Finance)
06:58AM	BD Surpasses 1 Billion Injection Device Orders in Support of COVID-19 Vaccination Efforts Around the World (PR Newswire)
Dec-10-20 06:22PM	Becton Dickinson Expects Covid Testing Sales to Hit $1.5 Billion (GuruFocus.com)
Dec-09-20 02:00AM	New Clinical Trial Data Demonstrates BD Libertas Wearable Injector as a Drug Delivery System (PR Newswire)
Dec-07-20 12:33PM	Is BDX A Good Stock To Buy Now? (Insider Monkey)
Dec-05-20 01:20AM	It Might Not Be A Great Idea To Buy Becton, Dickinson and Company (NYSE:BDX) For Its Next Dividend (Simply Wall St.)
Dec-02-20 07:08AM	Becton Dickinson to invest $1.2 billion to expand pre-fillable syringe manufacturing capacity for COVID vaccination (MarketWatch)
07:00AM	BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years (PR Newswire)
Dec-01-20 03:10PM	Is Natural Health Trends Corp. (NHTC) A Good Stock To Buy? (Insider Monkey)

Natural Health Trends Corp. engages in the provision of direct selling and e-commerce services. It offers personal care, and wellness products through NHT Global brand. The company was founded in December, 1988 and is headquartered in Hong Kong.

Open in Screener

PRTA

Prothena Corporation plc

May 10 • 04:00PM ET

21.34

Dollar change -0.66
Percentage change -3.00	%

Healthcare • Biotechnology • Ireland • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

PRTA Prothena Corporation plc daily Stock Chart

Held by: IWM VXF IWO IBB LABU SCHA VTWO VHT DFAS NUSC

Index	RUT	P/E	-	EPS (ttm)	-3.25	Insider Own	13.65%	Shs Outstand	53.68M	Perf Week	-6.93%
Market Cap	1.15B	Forward P/E	-	EPS next Y	-4.27	Insider Trans	-0.20%	Shs Float	46.39M	Perf Month	-8.33%
Income	-172.40M	PEG	-	EPS next Q	-1.22	Inst Own	97.77%	Short Float	14.55%	Perf Quarter	-24.81%
Sales	89.25M	P/S	12.84	EPS this Y	-70.41%	Inst Trans	-4.11%	Short Ratio	11.31	Perf Half Y	-39.56%
Book/sh	9.35	P/B	2.28	EPS next Y	9.24%	ROA	-25.26%	Short Interest	6.75M	Perf Year	-71.60%
Cash/sh	10.20	P/C	2.09	EPS next 5Y	34.07%	ROE	-31.07%	52W Range	19.65 - 77.36	Perf YTD	-41.28%
Dividend Est.	-	P/FCF	-	EPS past 5Y	6.83%	ROI	-33.64%	52W High	-72.41%	Beta	0.25
Dividend TTM	-	Quick Ratio	13.08	Sales past 5Y	4680.14%	Gross Margin	78.39%	52W Low	8.60%	ATR (14)	1.28
Dividend Ex-Date	-	Current Ratio	13.08	EPS Y/Y TTM	-23.02%	Oper. Margin	-242.28%	RSI (14)	42.22	Volatility	5.90% 5.06%
Employees	173	Debt/Eq	0.02	Sales Y/Y TTM	62.51%	Profit Margin	-193.17%	Recom	1.44	Target Price	64.88
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	-50.67%	Payout	-	Rel Volume	0.76	Prev Close	22.00
Sales Surprise	-97.69%	EPS Surprise	-15.77%	Sales Q/Q	-97.69%	Earnings	May 08 AMC	Avg Volume	596.76K	Price	21.34
SMA20	-1.29%	SMA50	-11.99%	SMA200	-43.51%	Trades		Volume	454,301	Change	-3.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-30-24	Downgrade	BofA Securities	Buy → Neutral	$68 → $38
Dec-12-23	Initiated	Deutsche Bank	Buy	$62
Apr-24-23	Initiated	SVB Securities	Outperform	$80
Jan-27-23	Initiated	Piper Sandler	Overweight	$94
Nov-04-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$52 → $55
Sep-28-22	Upgrade	BofA Securities	Neutral → Buy
Nov-19-21	Initiated	JMP Securities	Mkt Outperform	$77
Jun-18-21	Upgrade	BofA Securities	Underperform → Neutral	$12 → $49
Jun-08-21	Reiterated	Oppenheimer	Outperform	$45 → $54
May-26-21	Initiated	Citigroup	Buy	$39
Feb-26-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$14 → $28
Feb-12-21	Upgrade	Jefferies	Hold → Buy	$15 → $30
Feb-02-21	Upgrade	BTIG Research	Neutral → Buy	$29
Dec-07-20	Initiated	H.C. Wainwright	Buy	$22
Jul-09-20	Upgrade	Oppenheimer	Perform → Outperform	$16
Nov-19-19	Upgrade	Evercore ISI	In-line → Outperform	$14
May-21-18	Downgrade	Barclays	Equal Weight → Underweight	$14 → $12
Apr-23-18	Downgrade	Jefferies	Buy → Hold
Apr-05-18	Reiterated	Barclays	Overweight	$70 → $50
Nov-20-17	Downgrade	Wedbush	Outperform → Neutral	$75 → $55

Show Previous Ratings

May-09-24 11:52AM	Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses (Zacks)
May-08-24 10:56PM	PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:10PM	Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:14PM	Prothena: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports First Quarter 2024 Financial Results and Business Highlights (Business Wire)
04:05PM	Loading…
May-01-24 04:05PM	Prothena to Report First Quarter 2024 Financial Results on May 8 (Business Wire) +5.31%
Apr-25-24 10:01AM	Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline (Zacks)
Apr-15-24 04:05PM	Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma (Business Wire)
Mar-28-24 08:00AM	Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback (Investor's Business Daily)
Mar-05-24 04:05PM	Prothena to Participate in Upcoming Healthcare Conferences (Business Wire)
Mar-04-24 04:05PM	Prothena Appoints David Ford to Newly Created Chief People Officer Position (Business Wire)
Feb-21-24 04:05PM	Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate (Business Wire)
Feb-16-24 01:33PM	Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense (Zacks)
10:33AM	Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-15-24 04:50PM	Prothena: Q4 Earnings Snapshot (Associated Press Finance)
04:48PM	Loading…
04:48PM	Prothena Corp PLC (PRTA) Reports 2023 Financial Results and Provides 2024 Outlook (GuruFocus.com)
04:05PM	Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights (Business Wire)
Feb-08-24 04:05PM	Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 (Business Wire)
Jan-24-24 11:02PM	Prothena Corp PLC Chief Accounting Officer Sells 5,000 Shares (GuruFocus.com)
Jan-10-24 12:06PM	Prothena's (PRTA) Update on Pipeline Progress Disappoints (Zacks) -9.46%
05:38AM	Prothena (PRTA) Surges 12.3%: Is This an Indication of Further Gains? (Zacks)
Jan-08-24 08:30AM	Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs (Business Wire) -13.23%
Dec-21-23 09:01AM	Prothena Corp PLC Chief Accounting Officer Sells Company Shares (GuruFocus.com)
Dec-17-23 05:41AM	These 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche Bank (TipRanks)
Dec-01-23 11:05AM	Insider Sell Alert: Karin Walker of Prothena Corp PLC Cashes Out 5,000 Shares (GuruFocus.com) +7.09%
Nov-29-23 08:35AM	Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks (Investor's Business Daily)
Nov-20-23 06:00AM	FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success (Reuters)
Nov-17-23 01:35PM	Prothena (PRTA) Pipeline Shows Promise in a Tough AD Market (Zacks)
08:15AM	Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning (Investor's Business Daily)
Nov-03-23 11:34AM	Prothena (PRTA) Q3 Earnings Beat on Collaboration Revenue Hike (Zacks) +7.41%
07:03PM	Loading…
Nov-02-23 07:03PM	Prothena Corp PLC (PRTA) Reports Q3 2023 Financial Results (GuruFocus.com)
06:25PM	Prothena (PRTA) Beats Q3 Earnings and Revenue Estimates (Zacks)
05:24PM	Prothena: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports Third Quarter 2023 Financial Results and Business Highlights (Business Wire)
Oct-30-23 10:00AM	Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-26-23 04:09PM	Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment (Investor's Business Daily) -14.62%
04:05PM	Prothena to Report Third Quarter 2023 Financial Results on November 2 (Business Wire)
10:02AM	Prothena (PRTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
05:02AM	Insider Sell: Karin Walker Sells 5,000 Shares of Prothena Corp PLC (GuruFocus.com)
Oct-18-23 11:20AM	5 Biotech Stocks Set to Outpace Q3 Earnings Estimates (Zacks)
Oct-17-23 07:57AM	Prothena (PRTA) Soars 18.7%: Is Further Upside Left in the Stock? (Zacks) -9.92%
Oct-16-23 11:54AM	UPDATE 1-Prothena prepares for potential sale - Bloomberg News (Reuters) +18.69%
11:42AM	Prothena preparing for a potential sale - Bloomberg News (Reuters)
Oct-12-23 05:01AM	Insider Sell: Brandon Smith Sells 4,000 Shares of Prothena Corp PLC (GuruFocus.com)
Oct-07-23 03:33PM	12 Stock Picks From Our Healthcare Roundtable Pros. Weight Loss Isnt the Only Big Deal in Medicine. (Barrons.com)
Oct-05-23 09:01AM	Insider Sell: Chief Regulatory Officer Carol Karp Sells 5,000 Shares of Prothena Corp PLC (GuruFocus.com)
Sep-28-23 05:01AM	Insider Sell: Prothena Corp PLC's Chief Legal Officer Michael Malecek Sells 5,000 Shares (GuruFocus.com)
Sep-19-23 09:01PM	Insider Sell: Karin Walker Sells 5,000 Shares of Prothena Corp PLC (GuruFocus.com)
Sep-14-23 01:32PM	Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Shares of Prothena Corp PLC (GuruFocus.com)
Sep-07-23 12:00PM	Prothena (PRTA) Skyrockets 88.7% in 12 Months: Here's Why (Zacks)
Aug-31-23 04:05PM	Prothena to Participate in Upcoming Healthcare Conferences (Business Wire)
Aug-04-23 09:13AM	Prothena (PRTA) Q2 Earnings and Revenues Miss Estimates (Zacks) -7.30%
Aug-03-23 05:55PM	Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:49PM	Prothena: Q2 Earnings Snapshot (AP Finance)
04:05PM	Prothena Reports Second Quarter 2023 Financial Results and Business Highlights (Business Wire)
Aug-02-23 07:57AM	Prothena Corporation plc (NASDAQ:PRTA) Shares Could Be 36% Below Their Intrinsic Value Estimate (Simply Wall St.)
Jul-27-23 04:05PM	Prothena to Report Second Quarter 2023 Financial Results on August 3 (Business Wire)
Jul-18-23 05:36PM	The Fight Against Alzheimers Goes Beyond Plaque. Tangles Are a Target, Too. (Barrons.com)
05:36PM	The Fight Against Alzheimer Goes Beyond Plaque. Tangles Are a Target Too. (Barrons.com)
11:30AM	Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression (Zacks)
Jul-17-23 08:35AM	Prothena Presents New Research in the Treatment of Alzheimers Disease at Alzheimers Association International Conference® 2023 (AAIC®) (Business Wire)
Jul-13-23 09:22AM	Biotech Stock Roundup: BIIB, Eisai's Drug Update, NVAX Gains on Deal Amendment (Zacks)
Jul-11-23 04:05PM	Prothena to Present New Data from Alzheimers Disease Programs at Alzheimers Association International Conference® 2023 (AAIC®) (Business Wire)
08:59AM	Prothena (PRTA) Alzheimer's Disease Drug Licensed by BMY (Zacks)
Jul-10-23 04:10PM	Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody (Business Wire)
Jul-07-23 09:51AM	Biogen (BIIB), Eisai Get Full FDA Nod for Leqembi in Alzheimer's (Zacks)
Jun-27-23 04:05PM	Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab (Business Wire)
Jun-12-23 09:25AM	Biogen (BIIB), Eisai Alzheimer Drug Gets FDA Panel Endorsement (Zacks) +5.05%
Jun-08-23 12:41PM	Biogen (BIIB), Eisai's Alzheimer Drug Likely to Get Full FDA Nod (Zacks)
Jun-02-23 04:05PM	Prothena to Participate in Jefferies 2023 Healthcare Conference (Business Wire)
May-16-23 04:05PM	Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors (Business Wire)
May-10-23 06:13AM	Prothena Corporation plc (NASDAQ:PRTA) Analysts Just Trimmed Their Revenue Forecasts By 29% (Simply Wall St.)
May-05-23 12:27PM	Prothena (PRTA) Q1 Earnings and Revenues Miss Estimates (Zacks) +12.02%
May-04-23 06:45PM	Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:39PM	Prothena: Q1 Earnings Snapshot (AP Finance)
04:05PM	Prothena Reports First Quarter 2023 Financial Results and Business Highlights (Business Wire)
Apr-27-23 04:05PM	Prothena to Report First Quarter 2023 Financial Results on May 4 (Business Wire)
10:02AM	Analysts Estimate Prothena (PRTA) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-24-23 04:05PM	Prothena to Participate in 2023 Bank of America Healthcare Conference (Business Wire)
Apr-18-23 02:34PM	Companies Like Prothena (NASDAQ:PRTA) Can Afford To Invest In Growth (Simply Wall St.)
Apr-14-23 07:30AM	Walgreens (WBA) Declares Partnership With Prothena Corporation (Zacks)
Apr-13-23 08:00AM	Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimers Disease Clinical Trial (Business Wire) +5.17%
Apr-06-23 01:49PM	Prothena (PRTA) Gains 29% in One Year: Will the Momentum Continue? (Zacks)
Mar-31-23 09:20AM	Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023 (Business Wire)
Mar-21-23 04:05PM	Prothena to Participate in Stifel 2023 Virtual CNS Days (Business Wire)
Mar-14-23 04:05PM	Prothena to Highlight Next Generation Treatments for Alzheimers and Parkinsons Disease at the AD/PD 2023 Meeting (Business Wire)
Mar-01-23 05:20AM	Analysts Just Made A Major Revision To Their Prothena Corporation plc (NASDAQ:PRTA) Revenue Forecasts (Simply Wall St.)
Feb-24-23 11:36AM	Prothena (PRTA) Q4 Earnings and Revenues Beat Estimates (Zacks) +7.11%
Feb-23-23 04:05PM	Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights (Business Wire)
Feb-16-23 04:05PM	Prothena to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 (Business Wire)
Feb-05-23 05:03AM	TipRanks Perfect 10 List: Strong Catalysts Confirm the Bull Thesis on These 2 Stocks (TipRanks)
Feb-03-23 04:05PM	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-01-23 10:48AM	Prothena Touts Encouraging Data From Early-Stage Alzheimer's Candidate (Benzinga) -5.09%
Jan-31-23 04:05PM	Prothena Reports Topline Phase 1 Single Ascending Dose Study Results of PRX005, a Novel Anti-MTBR-Tau Antibody for the Potential Treatment of Alzheimers Disease (Business Wire)
Jan-15-23 09:01AM	Prothena (NASDAQ:PRTA) shareholder returns have been strong, earning 299% in 3 years (Simply Wall St.)
Dec-14-22 10:38PM	Prothena Announces Pricing of Public Offering of 3,250,000 Ordinary Shares (Business Wire) -8.32%
Dec-13-22 04:12PM	Prothena Announces Proposed Public Offering of Ordinary Shares (Business Wire)
Dec-12-22 11:30AM	Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022 (Business Wire) +5.47%
Nov-29-22 12:42PM	Biogen (BIIB) Down on Report of Death in Alzheimer's Study (Zacks)
Nov-22-22 10:07AM	Prothena (PRTA) Earns Milestone Payment From Novo Nordisk (Zacks)

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Walker Karin L	Chief Accounting Officer	Jan 24 '24	Option Exercise	13.53	5,000	67,650	5,000	Jan 24 07:01 PM
Walker Karin L	Chief Accounting Officer	Jan 24 '24	Sale	34.00	5,000	170,000	0	Jan 24 07:01 PM
Walker Karin L	Chief Accounting Officer	Dec 20 '23	Option Exercise	13.53	5,000	67,650	5,000	Dec 20 07:17 PM
Walker Karin L	Chief Accounting Officer	Dec 20 '23	Sale	37.19	5,000	185,952	0	Dec 20 07:17 PM
Walker Karin L	Chief Accounting Officer	Nov 30 '23	Option Exercise	13.53	5,000	67,650	5,000	Nov 30 06:24 PM
Walker Karin L	Chief Accounting Officer	Nov 30 '23	Sale	34.00	5,000	170,000	0	Nov 30 06:24 PM
Walker Karin L	Chief Accounting Officer	Oct 25 '23	Option Exercise	13.53	5,000	67,650	5,000	Oct 25 08:03 PM
Walker Karin L	Chief Accounting Officer	Oct 25 '23	Sale	41.04	5,000	205,191	0	Oct 25 08:03 PM
Smith Brandon S.	Chief Operating Officer	Oct 11 '23	Option Exercise	11.12	4,000	44,480	4,000	Oct 11 08:25 PM
Smith Brandon S.	Chief Operating Officer	Oct 11 '23	Sale	46.75	4,000	186,985	0	Oct 11 08:25 PM
Karp Carol D.	Chief Regulatory Officer	Oct 04 '23	Option Exercise	12.15	5,000	60,750	5,000	Oct 04 07:52 PM
Karp Carol D.	Chief Regulatory Officer	Oct 04 '23	Sale	46.62	5,000	233,084	0	Oct 04 07:52 PM
Malecek Michael J	Chief Legal Officer	Sep 27 '23	Option Exercise	10.27	5,000	51,350	5,000	Sep 27 08:35 PM
Malecek Michael J	Chief Legal Officer	Sep 27 '23	Sale	47.38	5,000	236,885	0	Sep 27 08:35 PM
Walker Karin L	Chief Accounting Officer	Sep 19 '23	Option Exercise	15.04	5,000	75,200	5,000	Sep 19 05:37 PM
Walker Karin L	Chief Accounting Officer	Sep 19 '23	Sale	52.36	5,000	261,807	0	Sep 19 05:37 PM
Garren Hideki	Chief Medical Officer	Sep 13 '23	Option Exercise	24.90	2,000	49,800	2,000	Sep 13 07:33 PM
Smith Brandon S.	Chief Operating Officer	Sep 13 '23	Option Exercise	11.12	4,000	44,480	4,000	Sep 13 07:32 PM
Smith Brandon S.	Chief Operating Officer	Sep 13 '23	Sale	55.49	4,000	221,963	0	Sep 13 07:32 PM
Garren Hideki	Chief Medical Officer	Sep 13 '23	Sale	55.48	2,000	110,952	0	Sep 13 07:33 PM
Karp Carol D.	Chief Regulatory Officer	Sep 06 '23	Option Exercise	12.15	5,000	60,750	5,000	Sep 06 07:42 PM
Karp Carol D.	Chief Regulatory Officer	Sep 06 '23	Sale	54.76	5,000	273,804	0	Sep 06 07:42 PM
Malecek Michael J	Chief Legal Officer	Aug 30 '23	Option Exercise	10.27	5,000	51,350	5,000	Aug 30 07:24 PM
Malecek Michael J	Chief Legal Officer	Aug 30 '23	Sale	55.01	5,000	275,066	0	Aug 30 07:24 PM
Walker Karin L	Chief Accounting Officer	Aug 18 '23	Option Exercise	15.04	5,000	75,200	5,000	Aug 18 08:37 PM
Walker Karin L	Chief Accounting Officer	Aug 18 '23	Sale	57.18	5,000	285,922	0	Aug 18 08:37 PM
Garren Hideki	Chief Medical Officer	Aug 16 '23	Option Exercise	24.90	2,000	49,800	2,000	Aug 16 09:15 PM
Smith Brandon S.	Chief Operating Officer	Aug 16 '23	Option Exercise	11.12	4,000	44,480	4,000	Aug 16 09:15 PM
Smith Brandon S.	Chief Operating Officer	Aug 16 '23	Sale	58.71	4,000	234,844	0	Aug 16 09:15 PM
Garren Hideki	Chief Medical Officer	Aug 16 '23	Sale	58.74	2,000	117,480	0	Aug 16 09:15 PM
Karp Carol D.	Chief Regulatory Officer	Aug 02 '23	Option Exercise	12.15	5,000	60,750	5,000	Aug 02 09:00 PM
Zago Wagner M.	Chief Scientific Officer	Aug 02 '23	Option Exercise	12.15	4,000	48,600	4,000	Aug 02 09:00 PM
Karp Carol D.	Chief Regulatory Officer	Aug 02 '23	Sale	67.01	5,000	335,072	0	Aug 02 09:00 PM
Zago Wagner M.	Chief Scientific Officer	Aug 02 '23	Sale	67.05	4,000	268,182	0	Aug 02 09:00 PM
Malecek Michael J	Chief Legal Officer	Jul 26 '23	Option Exercise	10.27	5,000	51,350	5,000	Jul 26 07:45 PM
Malecek Michael J	Chief Legal Officer	Jul 26 '23	Sale	62.33	5,000	311,638	0	Jul 26 07:45 PM
Walker Karin L	Chief Accounting Officer	Jul 19 '23	Option Exercise	15.04	5,000	75,200	5,000	Jul 19 08:50 PM
Walker Karin L	Chief Accounting Officer	Jul 19 '23	Sale	69.19	5,000	345,943	0	Jul 19 08:50 PM
Garren Hideki	Chief Medical Officer	Jul 12 '23	Option Exercise	24.90	2,000	49,800	2,000	Jul 12 08:45 PM
Smith Brandon S.	Chief Operating Officer	Jul 12 '23	Option Exercise	11.12	4,000	44,480	4,000	Jul 12 08:45 PM
Smith Brandon S.	Chief Operating Officer	Jul 12 '23	Sale	67.51	4,000	270,026	0	Jul 12 08:45 PM
Garren Hideki	Chief Medical Officer	Jul 12 '23	Sale	67.51	2,000	135,027	0	Jul 12 08:45 PM
Karp Carol D.	Chief Regulatory Officer	Jul 05 '23	Option Exercise	12.15	5,000	60,750	5,000	Jul 05 09:33 PM
Zago Wagner M.	Chief Scientific Officer	Jul 05 '23	Option Exercise	12.15	4,000	48,600	4,000	Jul 05 09:32 PM
Karp Carol D.	Chief Regulatory Officer	Jul 05 '23	Sale	68.13	5,000	340,636	0	Jul 05 09:33 PM
Zago Wagner M.	Chief Scientific Officer	Jul 05 '23	Sale	68.16	4,000	272,648	0	Jul 05 09:32 PM
Selkoe Dennis J.	Director	Jul 03 '23	Option Exercise	11.33	5,000	56,650	7,845	Jul 03 06:16 PM
Selkoe Dennis J.	Director	Jul 03 '23	Sale	67.43	5,000	337,150	2,845	Jul 03 06:16 PM
Malecek Michael J	Chief Legal Officer	Jun 28 '23	Option Exercise	10.27	5,000	51,350	5,000	Jun 28 08:45 PM
Malecek Michael J	Chief Legal Officer	Jun 28 '23	Sale	69.82	5,000	349,118	0	Jun 28 08:45 PM
Garren Hideki	Chief Medical Officer	Jun 16 '23	Option Exercise	24.90	7,331	182,542	7,331	Jun 16 07:31 PM
Garren Hideki	Chief Medical Officer	Jun 16 '23	Sale	74.00	7,331	542,494	0	Jun 16 07:31 PM
Garren Hideki	Chief Medical Officer	Jun 14 '23	Option Exercise	24.90	4,669	116,258	4,669	Jun 14 09:15 PM
Smith Brandon S.	Chief Operating Officer	Jun 14 '23	Option Exercise	11.12	5,333	59,303	5,333	Jun 14 09:15 PM
Smith Brandon S.	Chief Operating Officer	Jun 14 '23	Sale	73.98	5,333	394,562	0	Jun 14 09:15 PM
Garren Hideki	Chief Medical Officer	Jun 14 '23	Sale	74.22	4,669	346,516	0	Jun 14 09:15 PM
Zago Wagner M.	Chief Scientific Officer	Jun 07 '23	Option Exercise	26.09	19,000	495,750	19,000	Jun 07 09:49 PM
Karp Carol D.	Chief Regulatory Officer	Jun 07 '23	Option Exercise	13.19	20,000	263,700	20,000	Jun 07 09:49 PM
Karp Carol D.	Chief Regulatory Officer	Jun 07 '23	Sale	71.05	20,000	1,421,009	0	Jun 07 09:49 PM
Zago Wagner M.	Chief Scientific Officer	Jun 07 '23	Sale	71.06	19,000	1,350,224	0	Jun 07 09:49 PM
Malecek Michael J	Chief Legal Officer	May 31 '23	Option Exercise	10.27	5,000	51,350	5,000	May 31 09:30 PM
Malecek Michael J	Chief Legal Officer	May 31 '23	Sale	64.64	5,000	323,223	0	May 31 09:30 PM
Walker Karin L	Chief Accounting Officer	May 19 '23	Option Exercise	15.04	5,000	75,200	5,000	May 19 09:31 PM
Walker Karin L	Chief Accounting Officer	May 19 '23	Sale	74.00	5,000	369,978	0	May 19 09:31 PM
Nguyen Tran	Chief Strategy Officer and CFO	May 17 '23	Option Exercise	26.15	95,000	2,483,950	98,200	May 17 09:53 PM
Kinney Gene G.	President and CEO	May 17 '23	Option Exercise	29.81	45,000	1,341,450	57,793	May 17 09:54 PM
Nguyen Tran	Chief Strategy Officer and CFO	May 17 '23	Sale	73.99	95,000	7,028,921	3,200	May 17 09:53 PM
Kinney Gene G.	President and CEO	May 17 '23	Sale	73.70	45,000	3,316,292	12,793	May 17 09:54 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

NHTC

Natural Health Trends Corp.

PRTA

Prothena Corporation plc

Upgrade your FINVIZ experience